EP3651852
COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
10.7.2018EP published:
11.2.2026EP application number:
18746477.1
EPO information:
European Patent Register
Max expiry date:
9.7.2038Expiry date:
9.7.2026
Title in English:
COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIALanguage of the patent:
English
Timeline
Today
10.7.2018EP application
11.2.2026EP Publication
9.7.2026Expires
Owner
Name:
Genzyme CorporationAddress:
450 Water Street, Cambridge, MA 02141, US
Inventor
Name:
AKINC, AkinAddress:
Cambridge, MA 02142, US
Priority
Number:
201762530518 PDate:
10.7.2017Country:
US
Number:
201762599223 PDate:
15.12.2017Country:
US
Number:
201862614111 PDate:
5.1.2018Country:
US
Number:
201862673424 PDate:
18.5.2018Country:
US
Classification
Categories:
A61K 38/36, C12N 15/113, A61K 31/713, A61K 38/37, A61P 7/04